Clinical trial Recruiting at 1 site Observational Ages 18 and up

Predicting HFNC Failure in Acute Hypoxemic Respiratory Failure using Metabolomics and Clinical Data

Official title: Metabolomics and Clinical Data to Predict High-Flow Nasal Cannula Failure and Optimize Respiratory Support in Acute Hypoxemic Respiratory Failure

Run by Hospital del Mar Research Institute (IMIM) · NCT07607080 · Data updated 2026-11-12

This study tests whether metabolomic blood profiles combined with routine clinical data can predict which adults with acute hypoxemic respiratory failure on high-flow nasal cannula will fail and need escalation of care.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment300 (estimated)
SponsorHospital del Mar Research Institute (IMIM)
Academic / other
Locations1 site (Barcelona, Catalonia)
StatusRecruiting
StartedJune 4, 2026
Main results expectedMay 2029
Study endsMay 2029
Registry record updatedJune 8, 2026
Trial IDNCT07607080 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18 years) with ICU-admitted acute hypoxemic respiratory failure treated with HFNC within the first 24 hours of initiation.

Probably not a fit

Patients who do not have HFNC failure may not experience a direct benefit from the metabolomic approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study enrolls adults with acute hypoxemic respiratory failure who are started on HFNC in the ICU. Researchers collect clinical, physiological, and laboratory data, plus blood samples for metabolomic analysis, to identify patterns associated with HFNC failure. The aim is to build models that combine metabolomic and clinical information to predict escalation of respiratory support and important outcomes. Primary goals are to identify predictors of HFNC failure; secondary goals include associations with intubation, duration of support, ICU stay, and mortality. The study seeks to support personalized respiratory management for AHRF.

Why it matters

Potential benefit: If successful, clinicians could better anticipate HFNC failure and tailor respiratory strategies earlier to improve outcomes.

How similar studies have gone: Metabolomic approaches have shown potential in related critical care predictions, but application to HFNC failure prediction is exploratory.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult patients (≥18 years old).
* Admission to the intensive care unit (ICU) with acute hypoxemic respiratory failure (AHRF).
* Treatment with high-flow nasal cannula (HFNC) as the initial respiratory support strategy.
* Inclusion within the first 24 hours after HFNC initiation.
* Provision of informed consent by the patient or legally authorized representative.

Exclusion Criteria:

* Age \<18 years.
* Active do-not-resuscitate (DNR) orders or limitation of therapeutic effort.
* Refusal or inability to provide informed consent.
* Previous invasive mechanical ventilation before study inclusion.

Where it's running

  • Hospital del Mar
    Barcelona, Catalonia, Spain
    Recruiting

Study contacts

  • Principal investigator: Francisco José Parrilla-Gómez, MD, Phd — Hospital del Mar
  • Study coordinator: Francisco José Parrilla-Gómez, MD, Phd
  • Email: fparilla@hmar.cat
  • Phone: +34 747424848

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.